Guggenheim Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $664K | Sell |
41,501
-471
| -1% | -$7.54K | 0.01% | 1043 |
|
|
2025
Q1 | $717K | Buy |
41,972
+5,055
| +14% | +$86.4K | 0.01% | 1030 |
|
|
2024
Q4 | $914K | Buy |
36,917
+188
| +0.5% | +$4.66K | 0.01% | 954 |
|
|
2024
Q3 | $1.05M | Sell |
36,729
-809
| -2% | -$23.1K | 0.01% | 1075 |
|
|
2024
Q2 | $991K | Buy |
37,538
+3,311
| +10% | +$87.4K | 0.01% | 1119 |
|
|
2024
Q1 | $1.11M | Buy |
34,227
+6,352
| +23% | +$205K | 0.01% | 1140 |
|
|
2023
Q4 | $1.17M | Buy |
+27,875
| New | +$1.17M | 0.01% | 1069 |
|